Skip to main content
HR 4376 117th Congress House Foreign Trade and International Finance

USTRx Act

Introduced: July 9, 2021 Introduced by: Arrington, Jodey C. Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 9, 2021
Referred to the Subcommittee on Trade.
Jul 9, 2021
Referred to the House Committee on Ways and Means.
Jul 9, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Use Sovereignty To reduce Rx Act or the USTRx Act

This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the U.S. Trade Representative (USTR) to conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers.

The USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States.

What's happening now July 9, 2021

Referred to the Subcommittee on Trade.

 Committees of jurisdiction 2